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Abstract: Nuclear mRNA export is a highly complex and regulated process in cells. Cellular 
transcripts must undergo successful maturation processes, including splicing, 5'-, and 3'-end 
processing, which are essential for assembly of an export competent ribonucleoprotein 
particle. Many viruses replicate in the nucleus of the host cell and require cellular mRNA 
export factors to efficiently export viral transcripts. However, some viral mRNAs undergo 
aberrant mRNA processing, thus prompting the viruses to express their own specific mRNA 
export proteins to facilitate efficient export of viral transcripts and allowing translation in the 
cytoplasm. This review will focus on the .DSRVL¶V VDUFRPD-associated herpesvirus ORF57 
protein, a multifunctional protein involved in all stages of viral mRNA processing and that 
is essential for virus replication. Using the example of ORF57, we will describe cellular 
bulk mRNA export pathways and highlight their distinct features, before exploring how the 
virus has evolved to exploit these mechanisms. 
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1. Introduction 
.DSRVL¶VVDUFRPD-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8), belongs to the 
lymphotropic (Ȗ) herpesvirus subfamily [1] and is the causative agent of three human cancers: multicentric 
CastlePDQ¶VGLVHDVH0&' [2], primary effusion lymphoma (PEL) [3], and .DSRVL¶V VDUFRPDKS) [4]. 
While PEL and MCD are both rare B-cell lymphoproliferative disorders, KS, an aggressive tumour of 
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endothelial origin, has become one of the most common cancers in many sub-Saharan African countries 
where individuals are co-infected with HIV and KSHV [5]. Moreover, KS develops in states of 
immunosuppression and additionally affects patients after organ transplantation [6]. KS is characterised 
by an abnormal neovascularisation which thrives in a rich inflammatory microenvironment, initially 
affecting the skin and later progressing to internal organs and lymph nodes [7].  
Similar to other herpesviruses, KSHV can follow a latent or lytic replication programme in the 
infected host. The virus life cycle starts with replication in its primary target, B-cells from peripheral 
blood [8] and the oropharynx [9], and also in oral epithelial cells, which enables transmission between 
individuals by saliva [10,11]. The virus establishes latency in the majority of these infected cells, 
during which the genome is maintained as a large circular episome in the nucleus of the cell and only a 
very small subset of viral genes are expressed, resulting in no infectious virions being released. Under 
certain stimuli, such as hypoxia [12], lytic replication is reactivated in a small proportion of cells leading 
to expression of more than 80 transcripts, release of infectious virions and cell lysis. Importantly, lytic 
replication allows dissemination of the virus from the initial reservoir of infected cells to endothelial 
cells where tumours may develop. In the KS tumour, infected endothelial cells adopt characteristic 
spindle morphology with most remaining latently infected and few undergoing lytic replication [13]. 
Unlike other human oncogenic herpesviruses, such as Epstein-Barr (EBV) virus, in which the latent 
phase plays a key role in tumorigenesis [14], both the latent and the lytic phase are required for KS 
tumour development, with several lytic proteins exhibiting putative tumorigenic activities [15]. Hence, 
deciphering the molecular mechanisms that allow for lytic replication to occur are of great interest, as 
this may lead to a better understanding of KSHV-mediated pathogenesis and present novel approaches 
for therapeutic drugs targeting this process. 
This review will focus on the role of KSHV ORF57 (also called MTA-mRNA transcript accumulation) 
in the lytic life cycle of the virus. ORF57 is essential for virus lytic replication and functions in all 
stages of viral mRNA processing with a particular role in viral mRNA export. To highlight the role of 
ORF57 the concept of mammalian mRNA export will first be explored. 
2. Cellular mRNA Export and Viruses 
2.1. Introduction to Cellular mRNA Export 
A characteristic feature of eukaryotic cells is compartmentalization, which necessitates the presence 
of specific transport mechanisms allowing macromolecules to travel between the compartments. One 
such group of macromolecules are cellular mRNAs, which are produced in the nucleus, but must be 
exported into the cytoplasm in order for translation to occur. The physical separation of mRNA 
production and utilisation allows for the presence of multiple regulatory and quality control mechanisms. 
Accordingly, the majority of primary transcripts undergo multiple specific maturation steps turning 
precursor mRNA (pre-mRNA) to mRNA, including splicing, 5'-, and 3'-end processing. Failure to 
proceed through this process results in nuclear retention or degradation of the mRNA [16±21]. Opposed 
to this, successful mRNA processing is directly linked to nuclear export, as each step triggers recruitment 
of protein factors necessary for mRNA export [22±24]. 
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Viruses replicating their genome in the nucleus of the host cell also face the challenge of specifically 
exporting their mRNAs into the cytoplasm. In this section we will highlight cellular mRNA export 
pathways and show how some viruses exploit or circumvent these pathways for their own replication, 
before exploring KSHV ORF57-mediated mRNA export in detail. 
2.2. Cellular Bulk mRNA Export and the TREX Complex  
When leaving the nucleus, all mRNA needs to pass through selective and well controlled channels 
in the nuclear envelope: the nuclear pore complexes (NPCs), formed by nucleoporins. Hence, all  
export-competent ribonucleoproteins (RNPs) contain specific adapter proteins and export receptors 
that are targeted to the NPC. Cellular bulk mRNA export is facilitated via the export adapter 
transcription-coupled export (TREX) complex and the export receptor Nxf1/TAP (Mex67 in S. cerevisiae) 
and Nxt1/p15 (Mtr2 in S. cerevisiae) [25±27]. Table 1 lists all known components of TREX.  
Table 1. Known components of the human transcription-coupled export (TREX) complex. 
TREX 
Component Alternative Name S. cerevisiae Ortholog Known Interactions in TREX 
UAP56 BAT1, DDX39B Sub2 Aly, CIP29 [28], Chtop [29], UIF [30], THO [23], SKAR, ZC11A [31] 
DDX39 URH49, DDX39A Sub2 Aly [32], UIF [30], CIP29 [33] 
Aly Ref, Alyref, Thoc4, Bef Yra1 UAP56 [34], Chtop [29], Thoc5, 
Thoc2 [35] 
CIP29 HCC1, Tho1, Sarnp Tho1 UAP56 [28] 
UIF FYTTD1 - UAP56 [30] 
Chtop SRAG, CAO77 FOP - UAP56, Aly [29] 
SKAR pDIP3, PolDIP3 - ? 
ZC11A ZC3H11A - ? 
Thoc1 Hpr1, p84 Hpr1 Part of THO [35] 
Thoc2 Tho2 Tho2 Aly, Part of THO [35] 
Thoc5 fSAP79, Fmip - Aly, Part of THO [35] 
Thoc6 fSAP35, WDR58 - Part of THO [35] 
Thoc7 fSAP24 - Part of THO [35] 
Tex1 Thoc3 Tex1 Part of THO [35] 
Studies using various model organisms have shown a great degree of conservation of the TREX 
complex between plants, yeast and higher eukaryotes [25,36±38]. In this review we will focus on the 
human TREX complex (hereafter referred to as TREX), unless otherwise specified. Figure 1 provides 
some schematics showing known components and assembly of the TREX complex. 
Since mRNAs differ greatly, recognition of cargo by the TREX complex must be independent of 
features such as sequence, length and structure. Exceptions are found in less abundant types of mRNA, 
such as intron-less mRNAs, where only recently a specific consensus element was identified to recruit 
the TREX complex [39,40]. Instead, nuclear bulk mRNA export is directly linked to mRNA biogenesis, 
coupling successful mRNA processing and maturation to a stepwise assembly of the mRNP. The first 
processing event is the addition of a 5' cap, where a 7-methylguanosine (m7G) is added by an unusual 5'-5' 
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linkage to the first nucleotide of the transcript, in order to protect the nascent pre-mRNA from 5'±3' 
degradation [41]. Nuclear export is regulated by the 5' cap, as localisation of the TREX complex to the 5' 
end of the mRNA has been shown to be cap dependent. Aly and THO, two components of the TREX 
complex, interact directly with cap binding protein 80 (CBP80), a member of the cap-binding complex 
(CBC) [22,35,42] (Figure 1). Consequently, uncapped mRNAs have been shown to be poorly exported 
from the nucleus in microinjected Xenopus oozytes [22].  
Figure 1. Formation of transcription-coupled export (TREX) on the 5'-end of the mRNA 
through direct interactions with the cap-binding complex (yellow).  
 
After capping, the transcript is spliced to remove the non-coding intronic regions. In 2000 and 2001, 
studies emerged linking splicing to mRNA export in higher eukaryotes through a direct interaction of the 
export adapter protein Aly and a conserved DEAD-box helicase UAP56 [24,43]. Subsequent studies found 
Aly and UAP56 interact with a protein complex known as the exon-junction complex (EJC), which is 
formed 20±24 nucleotides upstream of each exon-exon junction [44]. Because of its association with export 
factors, the EJC was initially suggested to form a link between splicing and export, but more recently 
evidence emerged showing that the EJC functions in processes distinct to TREX and post-mRNA export, 
such as enhancement of translation, mRNA localization and nonsense-mediated decay (NMD) [45±47]. 
Two specific proteins in the EJC have been associated with translational enhancement of spliced 
transcripts, namely PYM and SKAR [48,49]. However, an independent study also identified SKAR as 
a component of the TREX complex [28]. Furthermore, SKAR, together with the protein ZC11A, has 
been shown to associate with TREX components in an ATP-dependent manner and play a role in 
mRNA export [31]. This suggests that the components of each complex may be multifunctional and 
there may also be dynamic remodeling and interplay between the EJC and TREX, involving individual 
members of both complexes. Further work, therefore, is needed to clarify the role of SKAR and 
whether the protein, as initially suspected with UAP56 and Aly, might be part of both the EJC and 
TREX and therefore provide a link between these two complexes. Both Aly and UAP56 have since 
been shown to be central components of the TREX complex, where they form an ATP-dependent 
trimeric complex with CIP29 [28]. Furthermore, the UAP56 paralogue, DDX39, which shares 90% 
sequence identity and 96% sequence similarity, has also been shown to interact with Aly [32] and 
CIP29 [33]. While UAP56 and DDX39 have redundant and overlapping functions in TREX, DDX39 has 
been proposed to target a functionally distinct subset of mRNAs [33]. UAP56 also associates with Chtop, 
a protein first identified by proteomic analysis of immunopurified TREX [28], in an ATP-dependent 
manner [29]. While CIP29 can bind UAP56 simultaneously with Aly, Chtop binding can be outcompeted 
by the presence of Aly, indicating consecutive loading of both proteins onto TREX. Recruited by UAP56, 
which acts as an ATP-dependent assembly factor, these TREX components bind exclusively to the  
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5'-end of the mRNA (Figure 2) [22,28,29]. Hence, both capping and splicing are necessary for 
assembly and function of the TREX complex [22±24].  
Figure 2. UAP56 assembles the TREX complex in an ATP-dependent manner. 
 
TREX formation in yeast appears to be dependent on transcription. During this process the THO 
complex²tightly associated proteins forming a sub-complex of the TREX complex²associates with 
the nascent RNA. It is believed that in yeast the THO complex recruits the remaining TREX complex. 
Accordingly, yeast strains with dysfunctional THO subunits show a severe blockage at mRNA export [50]. 
In contrast, knockdown of metazoan THO subunits results only in limited loss of function, with the 
vast majority of mRNAs still being exported [51]. Previous reports show that THO associates directly 
with the RNA-helicase UAP56, but unlike the interactions of UAP56 with Aly and CIP29, this 
interaction takes place in an ATP-independent manner [28]. In contrast, a more recent study suggests 
that THO associates only with Aly and not UAP56 [35]. Results show a direct interaction between Aly 
and the THO components Thoc2 and Thoc5, contradicting previous findings [28,52] and highlighting 
the complexity of working with a dynamically remodeled multi-protein complex. While knockdown of 
UAP56 and its paralogue, DDX39, abolishes virtually all mRNA export, redundancy has been reported 
for other components of TREX, for example Aly. Serine/arginine rich proteins (SR proteins) 9G8, 
SRp20 and SF2/ASF can link export receptor Nxf1/TAP-binding to spliced mRNA [53]. Furthermore, 
UIF (UAP56 interacting factor) has been shown to interact with UAP56 and Nxf1/TAP [30]. 
Importantly, individual knockdown of Aly or UIF does not significantly inhibit bulk mRNA export, 
however, depletion of both proteins leads to an almost complete loss of mRNA export, showing a 
similar phenotype as UAP56/DDX39 knockdown. This adds to a further complexity of the key 
components of TREX with redundant proteins having essential roles in mRNA export.  
It is also believed that the final mRNA maturation steps, 3'-end cleavage and polyadenylation, are 
coupled to the recruitment of Aly onto the TREX complex. In yeast, the Aly homologue Yra1 is 
recruited to the UAP56 homologue Sub2 via the 3'-end processing factor Pcf11. Sub2 uses the same 
binding region in Yra1 that is necessary for the interaction with Pcf11, suggesting mutually exclusive 
interactions [54]. Furthermore, it has been shown that Pcf11 displacement by an RNA and ATP loaded 
Sub2 gives way for Clp1, a subunit of the cleavage-polyadenylation factor CF1A, to bind Pcf11 [55]. 
Since this interaction is essential for a functioning cleavage-polyadenylation complex, successful 
mRNA 3'-end processing is coupled to formation of the TREX complex [56,57]. The interaction of Aly 
and Pcf11 is conserved in metazoans, also indicating coupling of mRNA 3'-end processing and export in 
higher organisms [54]. Interestingly, a recent report indicates Aly is not the only TREX component with 
an influence on 3'-end processing [58]. Thoc5 has been found to interact with pre-mRNA cleavage and 
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polyadenylation factor CFIm68 and recruit it onto the 5'-end of target genes. This interaction then affects 
a choice of alternative polyadenylation sites and lengthening of the 3'-UTR. Considering that alternative 
polyadenylation is known to be a control mechanism for gene expression [59], this highlights new roles of 
THO in TREX and pre-mRNA processing. 
As mentioned previously, an mRNP requires the additional recruitment of export receptors that 
specifically interact with the NPC to be considered export competent. For this, TREX acts as a binding 
platform for the non-karyopherin heterodimer of Nxf1/TAP and Nxt1/p15. Once ATP-bound UAP56 is 
associated with Aly, CIP29, Chtop and the THO complex, Aly and Thoc5 bind Nxf1/TAP directly [52]. 
This induces a conformational change in the export receptor which allows for RNA binding [60]. 
Furthermore, binding and handover of mRNA to Nxf1/TAP leads to displacement of UAP56 which 
then leaves TREX [61], as shown in Figure 3.  
Figure 3. Binding of Nxf1/TAP to Aly and Thoc5 induces a conformational change in the 
protein which allows RNA binding [60] and leads to the release of UAP56. 
 
Post-translational methylation of Aly within its Nxf1/TAP- and RNA-binding domain reduces its 
affinity for RNA and facilitates the handover of the mRNA from Aly to Nxf1/TAP [61,62]. Recent 
research has also shown that Chtop is able to bind Nxf1/TAP, a process necessary for mRNA handover 
from Aly to Nxf1/TAP [29]. The interaction of Chtop with Nxf1/TAP, which is regulated by the 
methylation status of Chtop, is mutually exclusive of Thoc5, however, both proteins exist in the same 
complex [29]. This indicates further remodeling of the complex and as such the order of binding and 
remodeling at the point in mRNA export remains to be fully elucidated (Figure 4). However, the 
mRNA transfer allows docking of the mRNP to the NPC via a transient interaction of Nxf1/TAP and 
Nxt1/p15 with phenylalanine/glycine (FG)-rich nucleoporins and subsequent translocation through the 
central channel (for a more detailed review see [63]).  
Figure 4. Handover of mRNA from TREX onto Nxf1/TAP and translocation through the 
nuclear pore complex (NPC). 
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Several human herpesviruses, including KSHV, Epstein-Barr virus, herpes simplex virus type 1 and 
human cytomegalovirus, have been shown to recruit various components of the TREX complex onto 
their mRNA in order to facilitate nuclear export of viral transcripts. As this forms the focus of our 
review, we will explore this area in further detail below. Simple retroviruses have also been shown to 
utilise human Nxf1/TAP and Nxt1/p15 to facilitate nuclear export of specific viral pre-mRNAs, but 
without association of the TREX complex as an adapter protein complex. Interestingly, research into 
the nuclear export of the incompletely spliced mRNA from Mason Pfizer Monkey Virus (MPMV) first 
identified Nxf1/TAP as a nuclear export factor in metazoans and gave way to research uncovering the 
major cellular mRNA export pathway [64,65]. The incompletely spliced RNAs from MPMV were found 
to contain a highly structured, cis-acting sequence, termed the constitutive transport element (CTE), 
sufficient for nuclear export [64]. Studies using type D retrovirus RNAs subsequently identified 
Nxf1/TAP as the cellular factor directly binding to the CTE and facilitating nuclear export [65]. 
Influenza A virus has also been shown to utilise the Nxf1/TAP pathway [66]. Interestingly, different 
subsets of viral mRNA appear to have different requirements for the presence of TREX components 
and/or Nxf1/TAP. While viral intron-less mRNAs coding for early gene products showed a weak 
dependency on Nxf1/TAP, export of late intron-less mRNA was strongly dependent on the presence of 
the nuclear export receptor. Furthermore, export of unspliced, intron containing viral mRNAs was 
reliant on both Nxf1/TAP and UAP56, whereas Aly, in addition to UAP56 and Nxf1/TAP was also 
recruited to spliced viral mRNA. This indicates that spliced viral mRNAs are processed in a manner 
similar to cellular transcripts and recruit the complete TREX complex, whereas unspliced or 
intron-less mRNAs utilise a viral adapter protein for the interaction with UAP56 and/or Nxf1/TAP. 
However, this adapter protein has yet to be identified.  
2.3. CRM1-Dependent mRNA Export 
While the CRM1-dependent export pathway is commonly used to export non-coding RNAs, such as 
ribosomal RNAs (rRNAs) and small nuclear RNAs (snRNAs) [67], as well as proteins [68], only a 
very small subset of cellular mRNAs utilise this pathway. Prominent examples are Cd83, Fos and 
cyclin D1 [69±71]. CRM1 (also known as exportin-1) belongs to the conserved karyopherin family of 
nuclear export receptors. It is structurally different from Nxf1/TAP, lacks RNA binding properties, but 
recognises leucine-rich-type nuclear export signals (NES) within proteins [72,73]. Accordingly, an 
NES containing adapter protein is needed for bridging the mRNA±CRM1 interaction. All karyopherins 
are regulated by the small GTPase Ran [74,75]. Exportins, such as CRM1, only bind their cargo in the 
nucleus when loaded with RanGTP and dissociate from it upon GTP hydrolysis. A gradient of 
RanGTP across the nuclear membrane generates the driving force and ensures directionality of 
transport towards the cytoplasm, where only GDP-bound Ran exists [76]. The presence of RanGAP 
(Ran-GTPase-activating protein) in the cytoplasm ensures GTP hydrolysis and release of the cargo 
from CRM1 [76].  
The CRM1 dependent export pathway is exploited by complex retroviruses, such as HIV, for 
exporting their unspliced or partially spliced mRNAs. HIV, like all members of the lentivirus family, 
expresses Rev as a viral adapter protein. Rev contains a leucine-rich sequence serving as an NES and 
is therefore able to bind CRM1 [73]. It also binds RNAs containing a highly structured cis-acting motif 
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termed the Rev response element (RRE), which enables Rev to bridge the interaction between RNA 
and export receptor [77,78]. Another well characterised viral interaction partner for CRM1 is Rex, 
expressed by human T-cell leukemia virus (HTLV), which functions similar to Rev [79,80]. A recent 
review by Shida gives further details about RNA export in retroviruses [81]. 
2.4. Nuclear Budding of Large Nuclear mRNPs 
Recently it has been reported for the first time that some mRNAs leave the nucleus without 
traveling through the NPC. This novel pathway describes large mRNPs leaving the nucleus by budding 
from the inner and outer nuclear membrane in Drosophila muscle cells [82]. RNA granules were found 
to associate with C-terminal fragments of a Wg receptor involved in Wnt-signalling during synapse 
development. The exported transcripts encoded postsynaptic proteins, which function locally in synapse 
assembly [82]. Mutations interfering with foci assembly caused formation of undifferentiated synapse 
boutons, which provides a fascinating connection to previous studies describing diseases such as muscular 
dystrophies as a result of faulty proteins of the inner-nuclear membrane [82±84]. Moreover, the mechanism 
of this process is beginning to be dissected, as the AAA-ATPase torsin has been identified as a key 
component of this pathway [85]. In mutants deficient in torsin, these large mRNPs are not exported 
and instead accumulate in the perinuclear space. Interestingly, this pathway bears great similarity to 
herpesvirus capsids budding from the nuclear membrane after assembly in the nucleus. These 
multimegadalton complexes are too large to travel through the NPC and instead leave the nucleus by 
inner-nuclear-membrane envelopment and outer-nuclear-membrane de-envelopment [86].  
3. ORF57  
Research over the last decade from several laboratories has identified KSHV open reading frame (ORF) 
57 that functions as a viral SR protein with multiple roles throughout viral mRNA processing [87±91], like 
its well studied homologues in other herpesviruses: ICP27 of herpes simplex virus type 1 [92,93], 
Mta/SM of Epstein-Barr virus [94,95], UL69 of human cytomegalovirus [96], ORF4 of varicella-zoster 
virus [97], and ORF57 of herpesvirus saimiri [98±101]. The multiple functions of KSHV ORF57 range 
from potential roles in transcription and splicing to viral mRNA stability and export, as well as 
translational enhancement [87,91,102±105]. Due to this far-reaching multi-functionality, ORF57 is 
able to interact with multiple viral and cellular proteins. The following section will explore the role of 
ORF57 in virus lytic replication.  
3.1. ORF57 Interactions with TREX to Mediate Export of Viral mRNA 
Herpesviruses, including KSHV, replicate in the nucleus of the host cell and produce numerous 
lytic intron-less mRNAs. However, as previously mentioned, the processes of transcription, splicing 
and mRNA nuclear export are intimately linked. Indeed, the recruitment of protein complexes 
including TREX and the EJC are splicing-dependent [23]. This poses a significant stumbling block for 
KSHV lytic replication, as numerous viral mRNAs are intron-less, meaning they do not undergo 
splicing and therefore cannot recruit TREX via the splicing-dependent mechanism. To overcome this 
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obstacle and promote efficient nuclear export of viral lytic intron-less transcripts, KSHV encodes the 
immediate-early protein ORF57 [106,107].  
The first interaction identified between ORF57 and a TREX complex component was with the 
export adapter protein Aly [90]. ORF57 is now known to bind directly to Aly and through this 
interaction recruit UAP56 and subsequently the entire TREX complex onto viral mRNA (Figure 5). 
Similar to mammalian mRNA export mechanisms, Aly bridges the interaction to Nxf1/TAP which 
facilitates viral mRNA export through the NPC [87]. Notably, trans-dominant Aly mutants which 
prevented assembly of the complete TREX complex, but were still able to interact with ORF57 as well 
as Nxf1/TAP, showed a decrease in viral intron-less mRNA export and virus replication [87]. Hence, 
the presence of ORF57, Aly and the nuclear export factor Nxf1/TAP on viral mRNA alone are not 
sufficient for vRNP export. Another interesting observation is that ORF57 shuttles through the 
nucleolus during the viral mRNA export process. Accordingly, all components of TREX can be seen to 
relocalise to the nucleolus with ORF57 and, importantly, the nucleolus appears to be essential for 
mRNA export both in KSHV [88] and in the model gamma-2 herpesvirus, herpesvirus saimiri [98]. 
However, the exact reason for this relocalisation remains to be elucidated, although it is clear that 
shuttling throughout different cellular compartments is an essential feature of ORF57. Current 
evidence suggests that shuttling between the nucleus and nucleolus occurs prior to exiting the nucleus 
into the cytoplasm and then being recycled into the nucleus again [107] (Figure 5).  
Figure 5. Open reading frame (ORF) 57 recruits the TREX complex onto viral mRNA, 
relocalises to the nucleolus and leaves the nucleus through the NPCs. 
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This process is aided by three nuclear localization signals (NLS) encoded within ORF57, each of 
which is sufficient to function as an independent NLS and with the first two NLS functioning together 
as a nucleolar localization signal [98,107,108]. At which point ORF57 interacts with each of its protein 
partners throughout this shuttling process is currently not fully clear, and neither is the exact mechanism 
of nuclear import. Heterokaryon assays demonstrate the shuttling of ORF57 between the nucleus and 
cytoplasm [109] and work on herpesvirus saimiri suggests that ORF57 homologues can interact with 
members of the importin family [110,111], although to date no direct interaction has been shown 
between KSHV ORF57 and importins. Clearly, better understanding of the exact shuttling mechanisms 
of ORF57 is essential to fully understand its functional role within KSHV lytic replication. 
Interestingly, some reports have suggested that the ORF57-Aly interaction is not required for either 
mRNA export or viral replication [112,113]. Surprisingly, siRNA knockdown of Aly does not completely 
prevent viral mRNA export [105]. However, an explanation for this observation can be seen in the 
inherent redundancy within cellular mRNA export. Knock down of Aly in a cellular system results in 
an increase of a second compensatory export adapter, UIF, meaning that mRNA export can still occur, 
albeit at a slightly lower level [30]. Importantly, ORF57 has also been shown to interact directly with 
UIF and through this same redundancy mechanism recruit both Aly and UIF to viral mRNA to facilitate 
mRNA export [105]. Furthermore, siRNA knockdown of both Aly and UIF not only results in dramatically 
lowered levels of mRNA export, but also in a decrease of viral protein expression. This highlights the 
importance of the ORF57-TREX interaction mediated by Aly and UIF. Moreover, although ORF57 
binds directly with either Aly or UIF to recruit TREX, it also interacts with other cellular proteins involved 
in mRNA export. Interaction with the cellular mRNA export factors OTT3 and RBM15 has been shown 
to be important for the expression of KSHV transcripts [114]. A similar scenario was believed to be the 
case for herpes simplex virus type 1, where the interaction between Aly and the ORF57 homologue 
ICP27 was thought to be dispensable for mRNA export, however, recent analysis has shown for the 
first time that this interaction is required for efficient export of viral mRNA [115]. Mutational analysis 
based on previous structural data [116] demonstrated that knocking out three key residues in the 
ICP27-Aly interaction inhibited mRNA export, despite the fact that ICP27 has been shown to directly 
interact with TAP/Nxf1 [117]. 
ORF57 homologues have also been shown to enhance viral mRNA export through interaction with 
TREX. The IE4 protein of varicella-zoster virus interacts with several cellular export factors including 
ASF/SF2, 9G8, SRp20, Aly and TAP, and has been shown to facilitate the export of viral mRNAs via 
the TAP/Nxf1 export pathway [97]. Also, the Epstein-Barr virus EB2 protein interacts directly with 
Aly to promote viral mRNA export [118]. Interestingly, a direct interaction with Aly is not essential 
for all herpesviruses to export their mRNA, for example, human cytomegalovirus UL69 directly 
interacts with the DEAD-box helicase UAP56 [119], an essential component of TREX. These findings 
suggest that while the mechanism of interacting with the human cellular export machinery may vary 
between herpesviruses, the requirement of recruiting TREX to viral mRNAs via ORF57 and its 
homologues appears to be evolutionarily conserved. 
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3.2. ORF57 Functions Additional to Viral mRNA Export 
3.2.1. ORF57 Acts to Stabilise Viral mRNA 
It has been known for some time that as well as functioning in viral mRNA export, ORF57 also acts 
to stabilise RNA [113,120]. How ORF57 is recruited to viral RNAs has long been investigated, and it 
was not until recently that the first work identifying a mechanism was published. The majority of work 
investigating the enhancement of RNA stability has been performed on a KSHV non-coding RNA 
termed PAN (polyadenylated nuclear RNA), a long non-coding RNA (lncRNA), which contains a 
recognition sequence for ORF57, or ORE (ORF57 response element). The PAN ORE is a nine nucleotide 
sequence confirmed by two independent studies and is able to confer ORF57 responsiveness when 
transferred to a reporter construct [121,122]. Interestingly, a further ORE has also been identified in 
the mRNA encoding vIL-6 consisting of the four core bases of the PAN ORE [123]. In both situations 
the ORE allows ORF57 binding and subsequent enhancement of RNA stability, although the mechanism 
by which stability is increased may differ. ORF57 has been shown to bind directly to the cellular 
polyadenylate-binding protein cytoplasmic 1 (PABPC1) and that PABPC1 is necessary for ORF57 to 
bind to the PAN ORE [124]. ORF57 also relocalises the majority of PABPC1 to the nucleus where 
PAN is retained. These observations suggest that PABPC1 is important for the stabilization of PAN in 
an ORF57-dependent manner. The mechanism of RNA stability of vIL-6 is slightly better understood. 
Binding of ORF57 to the mRNA via this minimal ORE acts as a competitive binding mechanism and 
protects the mRNA from miRNA-mediated degradation. Interestingly, ORF57 acts in a similar way to 
protect the cellular IL-6 mRNA from degradation, suggesting that ORF57 stabilises both viral and cellular 
mRNAs [123]. There are, however, several important questions remaining regarding ORF57-mediated 
RNA stabilization. As mentioned, work in this area is limited primarily to the non-coding PAN RNA, 
and a more in depth analysis of other viral, as well as cellular, RNAs would help to understand the role 
of ORF57 in RNA stability. It is also interesting to note that whilst PAN is the most highly expressed 
lytic transcript the function of PAN remains largely unknown. Moreover, ORF57 has been shown to 
stabilise several KSHV mRNAs (including ORF47, ORF59 and PAN) but have no effect on others 
(GCR and K5) [87,125], so understanding which RNAs ORF57 interacts with, the mechanism by which 
it is recruited to viral RNAs, and for what reason²whether it be stability, export or both²remain 
important questions. 
3.2.2. Transcriptional Enhancement by ORF57 
ORF57 function is not limited to interactions with cellular proteins or at the post-transcriptional level, 
it has also been shown to form protein-protein interactions with the viral protein RTA (replication 
transcriptional activator). Besides ORF57, RTA is the second protein essential for virus lytic replication, 
since it functions as a viral switch to induce lytic replication in latently infected cells [126,127]. By 
binding directly to promoter regions containing an RTA responsive element (RRE), RTA transactivates 
several viral and cellular promoters [128]. It is believed that ORF57 interacts with RTA to enhance the 
expression cascade of viral proteins and thereby increase the efficiency of KSHV reactivation. While 
ORF57 contains an A/T hook domain in the N-terminal region that confers DNA binding and has been 
shown to function as a transactivator for some viral genes, the role of ORF57 as a transcriptional 
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enhancer in lytic replication seems to be dependent on the interaction with RTA [103,125,129]. The 
interaction with ORF57 has been found to enhance the effect of RTA on several promoters, such as 
PAN/nut-1, Kaposin, ori-Lyt (L), K-bZIP, and TK [103,125,129]. It has to be noted though, that the 
synergistic effect of ORF57-RTA is promoter-, transcript-, and cell line-specific [129]. More recently, 
ORF57 has also been shown to bind directly to the KSHV transcription factor K-bZIP [130]. ChIP 
analysis demonstrated that ORF57 associates with the viral genome, with particular enrichment at the 
promoters of ORF4 and K-bZIP, in regions where K-bZIP itself binds. This further highlights the role 
ORF57 plays to regulate viral gene expression. 
3.2.3. The Role of ORF57 in Translational Enhancement 
Cellular mRNA processing is not only necessary for assembly of TREX, but also leads to the deposition 
of the EJC on the mRNA. As mentioned previously, the EJC is important for nonsense-mediated decay, 
mRNA localization and importantly translational enhancement [45±47]. SKAR and PYM, protein 
members of the EJC, have been shown to interact with multiple other translational enhancement 
proteins, resulting in enhancement of the pioneer round of translation [48,49]. PYM specifically is able to 
recruit the 48S pre-initiation complex through a direct interaction with the small ribosomal subunit [48]. 
Since the EJC is deposited on the mRNA in a splicing dependent manner, the virus is facing a 
conundrum similar to mRNA export. In order to circumvent this splicing-dependent step, ORF57 
interacts directly with PYM, which is sufficient to facilitate the assembly of the 48S pre-initiation 
complex onto viral intron-less mRNA (Figure 6) [104,131].  
Figure 6. ORF57 interacts directly with PYM to enhance translation.  
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Presence of a PYM mutant, which does not interact with either the EJC or 48S pre-initiation complex, 
but retained ORF57 binding ability, drastically reduced the presence of late KSHV proteins as well as 
KSHV virion production. Interestingly, ORF57 failed to interact with or recruit other components of the 
EJC onto viral intron-less transcripts [104]. Together these results highlight the role of the PYM-ORF57 
interaction in translational enhancement. Intriguingly, while the role of ORF57 in intron-less mRNA 
export is conserved amongst herpesviruses, no other ORF57 homologue has been shown to interact 
with PYM to enhance translation to date. 
3.2.4. ORF57 and Splicing of Viral Transcripts 
While numerous KSHV genes are intron-less, the virus also encodes multiple spliced transcripts.  
It is therefore not surprising that the virus should aim to enhance splicing of these genes. Accordingly, 
ORF57 has been shown to form a complex with the spliceosome and enhance splicing of viral lytic 
genes [91]. Specifically, the protein is able to enhance splicing of constructs containing a large exon 
upstream of a small intron, including viral and non-viral pre-mRNA constructs. This exon-intron 
distribution is found in the majority of KSHV spliced genes, but is distinct to mammalian mRNAs 
with small exons and large introns. Accordingly, constructs with oversized exons are only poorly 
spliced by the cellular splicing machinery, warranting ORF57 interference. While ORF57 has been 
found interacting with pre-mRNA in the presence of nuclear extracts, this could not be seen in the 
presence of purified ORF57, indicating that the interaction is not direct, but facilitated by cellular 
proteins, and that ORF57 utilises those proteins to modulate normal splicing [91]. A similar effect has 
been seen by ORF57 EBV homolog SM, which acts to influence the choice of splice site [132]. 
4. Concluding Remarks 
Since the discovery of KSHV in 1994 [4] there has been a large body of work investigating the 
latent-lytic switch and the immediate-early proteins that regulate the lytic cycle. The role that ORF57 
plays in all aspects of viral gene expression is critical to the full completion of the lytic cycle, as seen in 
ORF57 knock-out recombinant KSHV, which does not produce infectious virions [133]. Moreover, 
ORF57 homologues are conserved across all herpesviruses, their common function being to enhance viral 
transcript export and accumulation, highlighting the importance of this protein in the herpesvirus life-cycle. 
Our knowledge of the mechanisms surrounding nuclear mRNA export is still in its infancy. As 
such, our understanding of how viral export factors interact with these dynamic protein complexes and 
facilitate viral mRNA export is limited by our understanding of the cellular mechanisms. The recent 
discovery that ATP-driven remodeling of TREX takes place to allow mRNA export is then complicated 
by the addition of viral factors. ORF57 is known to bind directly to both Aly and UIF to recruit the 
complete TREX complex, but the mechanism by which TREX is then recruited is not fully understood. 
It is possible that the addition of ORF57 to this complex has no effect on the ATP-driven remodeling 
and handover of mRNA from Aly to TAP/Nxf1 and that ORF57 simply acts as a bridge between the 
viral mRNA and human export pathway. However, it would be interesting to investigate whether 
ORF57 interacts with TREX in such a way as to subvert the normal mechanism of mRNA export in 
any way, particularly as ORF57 is able to utilise either Aly or UIF for recruitment of TREX and export 
of viral mRNA [87,105]. 
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One important aspect of KSHV ORF57-mediated viral mRNA export that should be investigated 
further is the binding domains within ORF57 and Aly/UIF. Two recent studies highlighted the 
essential residues for binding of the ORF57 homologues ICP27 of herpes simplex virus, and ORF57 of 
herpesvirus saimiri to Aly [115,116]. Interestingly, removal of these binding sites severely hampered 
efficient mRNA export despite the previous observation in KSHV that UIF provides mRNA adapter 
redundancy. To date, KSHV ORF57 is the only herpesvirus mRNA export factor that has been shown 
to interact with UIF, however, there is no published work for or against the interaction with other 
herpesvirus ORF57 homologues. Interestingly, competition assays showed that ORF57 may preferentially 
bind Aly over UIF but this could also suggest that Aly and UIF share a binding site on ORF57 [105]. 
Furthermore, siRNA depletion of Aly and UIF separately has a moderate effect on mRNA export 
compared to near complete abolishment of export in a double knockout suggesting that both Aly and 
UIF could be required for the efficient recruitment of TREX for viral mRNA export. 
The high incidence of KS in the developing world means that the need for novel KSHV therapeutics 
is as essential as ever [5,134]. Importantly, knocking out ORF57 function can prevent the full lytic 
cycle due to the essential nature of viral mRNA export, making ORF57 an ideal target for novel 
therapeutics. Furthermore, studying the mechanism of mRNA export by ORF57 could help to further 
our understanding of various aspects of mRNA export. Needless to say, the study of ORF57 and its 
homologues in viral mRNA export has far-reaching implications in both our understanding of cellular 
mechanisms and in potential new anti-viral and anti-cancer therapeutics.  
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